JXN · Jackson Financial Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
JXN
this stock
Jackson Financial Inc.
|
$9.35B | +29.4% | +104.3% | 168.4 | 5.0% |
|
CILJF
China Life Insurance Co Ltd
|
$93.27B | +8.7% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$71.33B | +18.4% | — | — | 1.3% |
|
MET
Metlife Inc
|
$60.66B | +21.2% | +8.6% | 18.3 | 1.8% |
|
GWLIF
Great-West Lifeco Inc.
|
$57.84B | +31.6% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| JXN | +4.0% | +6.9% | +33.9% | +3.5% | +29.4% |
| SPY | +0.1% | -1.1% | +15.3% | -0.6% | +11.8% |
| vs SPY | +3.9% | +7.9% | +18.6% | +4.1% | +17.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.